{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,15]],"date-time":"2024-09-15T15:14:08Z","timestamp":1726413248628},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2017,12,16]],"date-time":"2017-12-16T00:00:00Z","timestamp":1513382400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1007\/s00277-017-3124-5","type":"journal-article","created":{"date-parts":[[2017,12,16]],"date-time":"2017-12-16T03:41:11Z","timestamp":1513395671000},"page":"351-354","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["HCV load as a possible prognostic factor in patients with HCV-related DLBCL"],"prefix":"10.1007","volume":"97","author":[{"given":"Xiang","family":"Zhou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katharina","family":"Lisenko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicola","family":"Lehners","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juliane","family":"Brandt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Cremer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Kriegsmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony Dick","family":"Ho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mathias","family":"Witzens-Harig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,12,16]]},"reference":[{"key":"3124_CR1","doi-asserted-by":"crossref","first-page":"3069","DOI":"10.1158\/1055-9965.EPI-08-0408","volume":"17","author":"LA Anderson","year":"2008","unstructured":"Anderson LA, Pfeiffer R, Warren JL et al (2008) Hematopoietic malignancies associated with viral and alcoholic hepatitis. Cancer Epidemiol Biomark Prev 17:3069\u20133075","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"3124_CR2","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.cgh.2008.02.011","volume":"6","author":"S Sanjose de","year":"2008","unstructured":"de Sanjose S, Benavente Y, Vajdic CM et al (2008) Hepatitis C and non-Hodgkin lymphoma among 4784 cases and 6269 controls from the International Lymphoma Epidemiology Consortium. Clin Gastroenterol Hepatol 6:451\u2013458","journal-title":"Clin Gastroenterol Hepatol"},{"key":"3124_CR3","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jhep.2013.03.018","volume":"59","author":"J Peveling-Oberhag","year":"2013","unstructured":"Peveling-Oberhag J, Arcaini L, Hansmann ML, Zeuzem S (2013) Hepatitis C-associated B-cell non-Hodgkin lymphomas. Epidemiology, molecular signature and clinical management. J Hepatol 59:169\u2013177","journal-title":"J Hepatol"},{"key":"3124_CR4","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.canep.2015.04.004","volume":"39","author":"YY Chen","year":"2015","unstructured":"Chen YY, Huang CE, Liang FW et al (2015) Prognostic impact of hepatitis C virus infection in patients with diffuse large B-cell lymphoma treated with immunochemotherapy in the context of a novel prognostic index. Cancer Epidemiol 39:382\u2013387","journal-title":"Cancer Epidemiol"},{"key":"3124_CR5","doi-asserted-by":"crossref","first-page":"489","DOI":"10.3324\/haematol.2013.094318","volume":"99","author":"M Merli","year":"2014","unstructured":"Merli M, Visco C, Spina M et al (2014) Outcome prediction of diffuse large B-cell lymphomas associated with hepatitis C virus infection: a study on behalf of the Fondazione Italiana Linfomi. Haematologica 99:489\u2013496","journal-title":"Haematologica"},{"key":"3124_CR6","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1080\/10428190701732861","volume":"49","author":"BB Park","year":"2008","unstructured":"Park BB, Kim JS, Lee YY et al (2008) Clinical characteristics and outcome for hepatitis C virus-positive diffuse large B-cell lymphoma. Leuk Lymphoma 49:88\u201394","journal-title":"Leuk Lymphoma"},{"key":"3124_CR7","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1200\/JCO.2005.01.5016","volume":"24","author":"C Besson","year":"2006","unstructured":"Besson C, Canioni D, Lepage E et al (2006) Characteristics and outcome of diffuse large B-cell lymphoma in hepatitis C virus-positive patients in LNH 93 and LNH 98 Groupe d\u2019Etude des Lymphomes de l\u2019Adulte programs. J Clin Oncol 24:953\u2013960","journal-title":"J Clin Oncol"},{"key":"3124_CR8","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1200\/JCO.2013.54.8800","volume":"32","author":"BD Cheson","year":"2014","unstructured":"Cheson BD, Fisher RI, Barrington SF et al (2014) Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. J Clin Oncol 32:3059\u20133068","journal-title":"J Clin Oncol"},{"key":"3124_CR9","first-page":"1860","volume":"31","author":"PP Carbone","year":"1971","unstructured":"Carbone PP, Kaplan HS, Musshoff K, Smithers DW, Tubiana M (1971) Report of the committee on Hodgkin\u2019s disease staging classification. Cancer Res 31:1860\u20131861","journal-title":"Cancer Res"},{"key":"3124_CR10","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/00000421-198212000-00014","volume":"5","author":"MM Oken","year":"1982","unstructured":"Oken MM, Creech RH, Tormey DC et al (1982) Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5:649\u2013655","journal-title":"Am J Clin Oncol"},{"key":"3124_CR11","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1200\/JCO.2006.09.2403","volume":"25","author":"BD Cheson","year":"2007","unstructured":"Cheson BD, Pfistner B, Juweid ME et al (2007) Revised response criteria for malignant lymphoma. J Clin Oncol 25:579\u2013586","journal-title":"J Clin Oncol"},{"key":"3124_CR12","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1056\/NEJM200107053450107","volume":"345","author":"GM Lauer","year":"2001","unstructured":"Lauer GM, Walker BD (2001) Hepatitis C virus infection. N Engl J Med 345:41\u201352","journal-title":"N Engl J Med"},{"key":"3124_CR13","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1056\/NEJMp1400986","volume":"370","author":"RT Chung","year":"2014","unstructured":"Chung RT, Baumert TF (2014) Curing chronic hepatitis C\u2014the arc of a medical triumph. N Engl J Med 370:1576\u20131578","journal-title":"N Engl J Med"},{"key":"3124_CR14","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1111\/liv.12825","volume":"35","author":"HA Torres","year":"2015","unstructured":"Torres HA, Mahale P (2015) Most patients with HCV-associated lymphoma present with mild liver disease: a call to revise antiviral treatment prioritization. Liver Int 35:1661\u20131664","journal-title":"Liver Int"},{"key":"3124_CR15","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/sj.thj.6200408","volume":"5","author":"E Iannitto","year":"2004","unstructured":"Iannitto E, Ammatuna E, Tripodo C et al (2004) Long-lasting remission of primary hepatic lymphoma and hepatitis C virus infection achieved by the alpha-interferon treatment. Hematol J 5:530\u2013533","journal-title":"Hematol J"},{"key":"3124_CR16","doi-asserted-by":"crossref","first-page":"278","DOI":"10.4254\/wjh.v3.i11.278","volume":"3","author":"AM Pellicelli","year":"2011","unstructured":"Pellicelli AM, Marignani M, Zoli V et al (2011) Hepatitis C virus-related B cell subtypes in non Hodgkin\u2019s lymphoma. World J Hepatol 3:278\u2013284","journal-title":"World J Hepatol"},{"key":"3124_CR17","doi-asserted-by":"crossref","first-page":"6841628","DOI":"10.1155\/2016\/6841628","volume":"2016","author":"A Tamori","year":"2016","unstructured":"Tamori A, Enomoto M, Kawada N (2016) Recent advances in antiviral therapy for chronic hepatitis C. Mediat Inflamm 2016:6841628","journal-title":"Mediat Inflamm"},{"key":"3124_CR18","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1111\/liv.12897","volume":"35","author":"P Carrier","year":"2015","unstructured":"Carrier P, Jaccard A, Jacques J et al (2015) HCV-associated B-cell non-Hodgkin lymphomas and new direct antiviral agents. Liver Int 35:2222\u20132227","journal-title":"Liver Int"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-017-3124-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-017-3124-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-017-3124-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,4]],"date-time":"2018-01-04T04:33:47Z","timestamp":1515040427000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-017-3124-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,16]]},"references-count":18,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["3124"],"URL":"https:\/\/doi.org\/10.1007\/s00277-017-3124-5","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"type":"print","value":"0939-5555"},{"type":"electronic","value":"1432-0584"}],"subject":[],"published":{"date-parts":[[2017,12,16]]}}}